PUBLICATIONS:

 

HEPATITIS A:

 

[pdf] G. Sánchez, L. Aragonès, M.I. Costafreda, E. Ribes, A. Bosch & R.M. Pintó. Capsid region involved in the hepatitis A virus binding to the glycophorin A of the erythrocyte membrane. Journal of Virology, 2004, 78: 9807-9813.

[pdf] G. Sánchez, C. Villena, A. Bosch & R.M. Pintó. Molecular detection and typing of hepatitis A virus. In “Methods in Public Health Microbiology”, Chapter 5, Humana Press, Totowa, New Jersey 2004, pp 103-114.

[pdf] G. Sánchez, R.M. Pintó & A. Bosch. A novel CD4+ T-helper lymphocyte epitope in the VP3 protein of the Hepatitis A virus. Journal of Medical Virology 2004, 72: 525-532.

[pdf] R. Gabrieli, G. Sánchez, A. Macaluso, F. Cenko, S. Bino, L. Palombi, E. Buonuomo, R.M. Pinto, A. Bosch & Maurizio Divizia. Hepatitis in Albanian children: molecular analysis of hepatitis A virus isolates. Journal of Medical Virology 2004, 72: 533-537.

[pdf] G. Sánchez, A. Bosch, G. Gómez-Mariano, E. Domingo & R.M. Pintó. Evidence for quasispecies distributions in the human hepatitis A virus genome.
Virology 2003, 315: 34-42.

[pdf] G. Sánchez, A. Bosch & R.M. Pintó. Genome variability and capsid structural constraints of hepatitis A virus. Journal of Virology. 2003, 77: 452-459.

[pdf] G. Sánchez, S. Caballero, S. Guix, A. Bosch, & R.M. Pintó. Antigenic hepatitis A structures may be produced in E. coli. Applied and Environmental Microbiology. 2003, 69: 1840-1843.

[pdf] G. Sánchez, R.M. Pintó, H. Vanaclocha & A. Bosch. Molecular characterization of hepatitis A virus isolates from a transcontinental shellfishborne outbreak. Journal of Clinical Microbiology. 2002, 40: 4148-4155.

[pdf] R.M Pintó, S. Guix, J.F. González-Dankaart, S. Caballero, G. Sánchez, K.J. Guo, E. Ribes & A. Bosch. Hepatitis A virus polyprotein processing by Escherichia coli proteases. The Journal of General Virology, 2002, 83: 359-368.

M. Buti, E. Jardi, E., A. Bosch, F. Rodríguez, G. Sánchez, R.M. Pintó, X. Costa, J.F. Sánchez-Ávila, M. Cotrina, R. Esteban & J. Guardia. Valoración de la técnica de PCR-Southern blot para el análisis de la viremia en pacientes con hepatitis aguda A. Gastroenterología y Hepatología. 2001, 24: 1-4.

R.M. Pintó , J.F. González-Dankaart, G. Sánchez, S. Guix, M.J. Gómara, M. García, I. Haro & A. Bosch. Immunogenicity of a synthetic peptide bearing a new epitope of hepatitis A virus. FEBS Letters. 1998, 438: 106-110.

A. Bosch, J.F. González-Dankaart, I. Haro, R. Gajardo, J.A. Pérez & R.M. Pintó.
A new continuous epitope of hepatitis A virus. Journal of Medical Virology. 1998, 54:95-102.

A. Bosch, K.-J. Guo, J.F. Gonzalez-Dankaart, X. Arnijas, S. Guix, G. Sanchez, E. Ribes & R.M. Pintó. Recombinant hepatitis A virus polyprotein expressed in E. coli assembles in subviral structures. In “Viral Hepatitis and Liver Disease”, M. Rizzeto, R.H. Purcell, J.L. Gerin, G. Verme (Eds.) 1997. Editorial Minerva Medica, Torino. pp 27-31.

J.A. Pérez, F. Mota, J.F. González-Dankaart, R. Pintó, A. Bosch, F.Reig & I. Haro.
Comparative study of antibody titers induced by synthetic peptides belonging to VP2 and VP3 capsid proteins of hepatitis A virus. In “Peptides 94", H. Maia (Ed.), 1996. Editorial ESCOM Science Publishers, Leiden. pp 821-822.

I. Haro, R.M. Pintó, J.F. González-Dankaart, J.A. Pérez, F. Reig & A. Bosch. Anti-hepatitis A virus antibody response elicited in mice by different forms of a synthetic VP1 peptide. Microbiology and Immunology 1995, 39: 485-490.

J.A. Pérez, J.F. González-Dankaart, F. Reig, R.M. Pintó, A. Bosch & I. Haro. Solid phase synthesis and immunogenicity of a VP3 peptide from hepatitis A virus. Biomedical Peptides, Proteins and Nucleic Acids 1995, 1: 93-100.

I. Haro, A.M. Culleré, J.A. Pérez, R.M. Pintó, A. Bosch & F. Reig. Solid phase synthesis and immunogenicity of an antigenic peptide from hepatitis A virus: Comparison of different systems for enhancing antibodies production. In “Innovation And Perspectives In Solid Phase Synthesis And Complementary Technologies", 1994. R. Epton (Ed), Editorial Mayflower Worlwide Ltd, Birmingham, pp 527-530.

I. Haro, A. Bosch & F. Reig. Synthetic peptides for the development of a hepatitis A vaccine. Use of liposomes as adjuvants. Current Topics in Peptide and Protein Research 1994, 1: 135-149.